Cochin Shipyard share price snaps 4-day rally, falls 4%. Should you too book profits?
The multibagger stock has faced significant gains, rising for four months in a row. Between March and June, Cochin Shipyard's share price is up 65%, with the scrip gaining 19% this month alone.
The rally in Cochin Shipyard shares can be attributed to overall positive sentiment for the defence stocks following the rise in India-Pakistan tensions in light of Operation Sindoor. The Nifty India Defence index is trading at all-time high levels as defence stocks witness strong buying momentum.
Analysts believe that the escalated need for defence equipment and systems has come to the fore, and the focus has now shifted to the execution of the order books to meet this expected demand, which is driving the defence stocks higher.
Omniscience Capital expects the Defence budget to be increased to 3% to 4% of the GDP from the current ~2% level. "With a $10 trillion GDP, the defence budget is expected to grow to more than $300 bn USD or around INR 30 lac crores. This implies a 16-17% annualised growth till 2035," it said.
However, amid a strong rally in Cochin Shipyard share price, technical analysts see a downside in the stock, advising caution for the time being.
Cochin Shipyard rallied over 107% in just 40 days and has now formed a bearish shooting star at the top, followed by a downside move, indicating profit booking, said Anshul Jain, Head of Research at Lakshmishree Investments.
"The recent exhaustion suggests that a short-term correction is underway. The stock is likely to test its previous swing high support zone around ₹ 2,150," he added. Traders should exercise caution at current levels, as the extended rally now looks due for a healthy pullback before any fresh upmove, Jain advised.
Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
14 minutes ago
- India.com
Jackpot for Gautam Adani as Adani Power wins Rs 24900000000 project in THIS state, company to set up…
Gautam Adani- File image New Delhi:In a major development, Gautam Adani-led Adani Power has announced that it has secured a Letter of Intent (LoI) from the Bihar State Power Generation Company Ltd (BSPGCL) to develop and operate a 2,400 megawatt greenfield thermal power plant in Bhagalpur District, Bihar. According to the company, the investment will be worth Rs USD 3 billion. The project is likely to play a pivotal role in pushing the state's industrial growth. 'We have won the bid to develop and operate a 2,400 MW thermal power project in Bihar. We will set up a new greenfield plant with an investment of USD 3 billion, which is expected to further aid industrialization in the state,' said S B Khyalia, CEO of Adani Power. Khyalia further added that the new plant would be an advanced, low-emission ultra-supercritical power station, designed to supply dependable, competitively priced, and high-quality power to the state. It is important to note that Adani Power is India's largest private thermal power producer. The company has installed thermal power capacity of 18,110 MW across 12 plants in various states, including Gujarat, Maharashtra, and Karnataka. Here are some of the key details: Adani Power emerged as the lowest bidder in a competitive tender process The company will supply 2,274 MW of energy to the North Bihar Power Distribution Company Ltd (NBPDCL) and South Bihar Power Distribution Company Ltd (SBPDCL) at a supply price of Rs 6.075 per KWh. The company is likely to receive the Letter of Award (LoA) soon, followed by the execution of a Power Supply Agreement (PSA) with the state utilities. The new facility will be a 3×800 MW ultra-supercritical power plant, built under the Design, Build, Finance, Own, and Operate (DBFOO) model. The first unit of the plant is scheduled to be commissioned within 48 months from the appointed date, and the last unit will be operational within 60 months. The project is set to generate significant employment According to the reports, the project will generate an estimated 10,000-12,000 jobs during the construction phase and 3,000 jobs once the plant is operational. Fuel for the power plant will be sourced from the allocated coal linkage under the Government of India's SHAKTI Policy.
Hans India
44 minutes ago
- Hans India
Cohance Lifesciences Announces ₹230 mn Investment and Progress on cGMP Oligonucleotide Facility at Hyderabad, India
Cohance Lifesciences Limited ('Cohance' or 'the Company'), a partner of choice for global innovator pharma companies, announced INR 230 million investment and significant progress on its new cGMP oligonucleotide building block manufacturing facility in Hyderabad, India. This strategic investment strengthens Cohance's integrated oligonucleotide platform and enhances its position as a preferred partner for emerging modalities. Cohance brings deep expertise in modified nucleosides and locked nucleic acids (LNA), with a proven track record in complex nucleoside and nucleic acid synthesis at the R&D stage. The new facility will enable the Company to take these high-value chemistries from laboratory scale to full commercial manufacturing, meeting the needs of innovators advancing oligonucleotide-based therapeutics. Integrated with pilot plant for early-stage synthesis and for non-GMP scale-up, the facility will add fit-for-purpose GMP capacity of up to 700 kg annually, with room for future expansion. This scale, combined with advanced environmental controls including ISO Class 8 clean rooms and RH-controlled areas, is designed to meet the stringent requirements of complex oligonucleotide building block production. Customer engagements are already underway, with audits planned in the coming quarters. Kilo lab validations and modified nucleotides are in progress, with GMP-grade PMO and LNA amidite validations expected to commence in CY26. Vivek Sharma, Executive Chairman, Cohance Lifesciences, said: 'Oligonucleotides are a fast-emerging therapeutic class, and innovators are seeking integrated, cost-efficient partners with scalable GMP capacity. This facility is a high-impact strategic investment that complements our pilot and scale-up assets, positioning Cohance to deliver with speed, quality, and flexibility while expanding our role in next-generation therapeutics.' This investment follows the Company's recently announced USD 10 million expansion of cGMP bioconjugation capabilities at NJ Bio in the United States. Together, these investments form part of Cohance's planned capacity expansion program across high-growth modalities, enhancing its ability to serve global innovators from early development to commercial supply.
India Today
2 hours ago
- India Today
US lacks ‘expertise' in dealing with India, says expert on Op Sindoor fallout
The United States mishandled its approach to India after Operation Sindoor, revealing a lack of understanding of how to engage with New Delhi, says Max Abrahms, an international security professor and author on terrorist to ANI, Abrahms said the Trump administration's conduct left India feeling slighted while Pakistan publicly praised Washington's role. 'Pakistan became very vocally supportive of the US role and recommended a Nobel Prize for Trump, whereas India really chipped at the level of US involvement and especially Trump claiming so much credit,' he argued the administration 'doesn't fully appreciate' India's global standing. 'India feels like it's not being fully respected and that the Trump administration doesn't fully appreciate its contributions or regard India as a fully independent country on the world stage,' he said. He was also sceptical of Trump's actual role in brokering the ceasefire. 'I cannot really say with any level of confidence exactly what the Trump administration's role was What I do know is that President Trump claimed a lot of personal responsibility for the end of that conflict.'Abrahms linked the tensions in India-US ties to disagreements over Russian oil imports, suggesting Washington's issues with New Delhi will hinge partly on Trump's talks with Vladimir Putin. 'In a weird way, that war in Russia is connected to US-India relations because Indian purchasing of Russian oil fuels the war in Ukraine,' he the importance of the Quad alliance — involving the US, India, Japan, and Australia — Abrahms said improved ties were essential to counter China. 'The China threat isn't going away and that is going to require the US to mend relations with allies in the Indo-Pacific region,' he also warned that the 'America First' approach could damage both economic and military relations. 'They think America could seal itself off But that's a dangerous path to go down. It can have a negative effect on the financial system, but also in terms of military ties,' he stressed that in a globalized world, US prosperity is linked to India's. 'If something's bad for the Indian economy, it's also not good for the US economy It is actually in the US interest for Indian economic growth to continue apace,' he said.- EndsWith inputs from ANITune InMust Watch
